pharmaceutical investing AbbVie to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 02 June
pharmaceutical investing AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia 29 May
pharmaceutical investing U.S. FDA Approves DECNUPAZTM for Treatment of Adult Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare and Aggressive Blood Cancer With Limited Treatment Options 27 May
